Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 16, Iss. 27, 2009-09 ,pp. : 3480-3675

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Variations in Cytochrome P450 2C9 and 2C19: A Review

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 1, 2017-01 ,pp. : 18-28

Bentham Science Publishers

Access to resources Recommend Favorite

Studies of Binding Modes of (S)-Mephenytoin to Wild Types and Mutants of Cytochrome P450 2C19 and 2C9 Using Homology Modeling and Computational Docking

By Oda Akifumi   Yamaotsu Noriyuki   Hirono Shuichi  

Pharmaceutical Research, Vol. 21, Iss. 12, 2004-12 ,pp. : 2270-2278

Springer Publishing Company

Access to resources Recommend Favorite

Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib

By Brenner S.S.   Herrlinger C.   Dilger K.   Murdter T.E.   Hofmann U.   Marx C.   Klotz U.  

Clinical Pharmacokinetics, Vol. 42, Iss. 3, 2003-01 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity

By Kealey Carmel   Chen Zhen   Christie Jason   Thorn Caroline F   Whitehead Alexander S   Price Maureen   Samaha Frederick F   Kimmel Stephen E  

Pharmacogenomics, Vol. 8, Iss. 3, 2007-03 ,pp. : 217-225

Future Medicine

Access to resources Recommend Favorite